ZA968482B - Therapeutic diet for metabolic abnormalities found in dogs with lymphoma. - Google Patents

Therapeutic diet for metabolic abnormalities found in dogs with lymphoma.

Info

Publication number
ZA968482B
ZA968482B ZA9608482A ZA968482A ZA968482B ZA 968482 B ZA968482 B ZA 968482B ZA 9608482 A ZA9608482 A ZA 9608482A ZA 968482 A ZA968482 A ZA 968482A ZA 968482 B ZA968482 B ZA 968482B
Authority
ZA
South Africa
Prior art keywords
omega
lymphoma
dogs
metabolic abnormalities
therapeutic diet
Prior art date
Application number
ZA9608482A
Other languages
English (en)
Inventor
Gregory K Ogilvie
Kathy L Gross
Deborah J Davenport
Michael S Hand
Original Assignee
Colgate Palmolive Co
Gregory K Ogilvie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24172105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA968482(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Colgate Palmolive Co, Gregory K Ogilvie filed Critical Colgate Palmolive Co
Publication of ZA968482B publication Critical patent/ZA968482B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9608482A 1995-10-10 1996-10-08 Therapeutic diet for metabolic abnormalities found in dogs with lymphoma. ZA968482B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/544,421 US5776913A (en) 1995-10-10 1995-10-10 Therapeutic diet for metabolic abnormalities found in animals with lymphoma

Publications (1)

Publication Number Publication Date
ZA968482B true ZA968482B (en) 1998-04-08

Family

ID=24172105

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9608482A ZA968482B (en) 1995-10-10 1996-10-08 Therapeutic diet for metabolic abnormalities found in dogs with lymphoma.

Country Status (16)

Country Link
US (1) US5776913A (es)
EP (1) EP0854681B1 (es)
JP (1) JP4216334B2 (es)
AT (1) ATE210928T1 (es)
AU (1) AU707341B2 (es)
BR (1) BR9611044A (es)
CA (1) CA2234249C (es)
DE (1) DE69618218T2 (es)
DK (1) DK0854681T3 (es)
ES (1) ES2170269T3 (es)
MX (1) MXPA98002779A (es)
NO (1) NO325357B1 (es)
NZ (1) NZ319911A (es)
TR (1) TR199800744T2 (es)
WO (1) WO1997013415A1 (es)
ZA (1) ZA968482B (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5891925A (en) * 1997-06-27 1999-04-06 Abbott Laboratories Diagnostic method for assessing the serum cholesterol response to low diets
US6039952A (en) * 1997-10-22 2000-03-21 The Iams Company Composition and method for improving clinical signs in animals with renal disease
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
AUPP887399A0 (en) * 1999-02-24 1999-03-25 Bartlett Grain Pty Ltd Animal feed formulae for the nutritional enrichment of foodstuffs
US6291496B1 (en) 1999-12-27 2001-09-18 Andrew J. Dannenberg Treating cancers associated with overexpression of class I family of receptor tyrosine kinases
US6436463B1 (en) * 2000-06-26 2002-08-20 Hill's Pet Nutrition, Inc. Pet food composition and method
JP4532822B2 (ja) * 2000-07-14 2010-08-25 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ペットの皮膚および皮を改善するための食餌性脂質
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
JP4600969B2 (ja) * 2002-01-22 2010-12-22 マース インコーポレーテッド 肥満動物のための体重管理システム
US20030138547A1 (en) * 2002-01-22 2003-07-24 Mars, Incorporated Weight management system for animals
GB0207830D0 (en) * 2002-04-04 2002-05-15 Mars Uk Ltd Animal composition
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US8841344B2 (en) * 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US6899904B2 (en) * 2002-11-14 2005-05-31 The Meow Mix Company Pet food compositions having electrostatically charged ingredient
US6841179B2 (en) 2002-11-14 2005-01-11 The Meow Mix Company Pet food compositions comprising electrostatically charged gelatin
US20060204636A1 (en) * 2002-12-23 2006-09-14 Butterwick Richard F Food for gastrointestinal health
US8034372B2 (en) * 2003-03-05 2011-10-11 Nestec, Ltd. Dietary supplement for athletic pets
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
FI20060154A7 (fi) 2003-08-18 2006-05-11 Btg Int Ltd Neurogeneratiivisten tilojen hoito
US7744917B2 (en) 2003-11-25 2010-06-29 Virginia Intellectual Properties Inc. Composition for animal consumption and method for reducing MAP kinase activity
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US20090214738A1 (en) * 2004-12-30 2009-08-27 Mark Lee Dierking Process for preparing a meat and carbohydrate based composition for consumption by felines
WO2006072084A2 (en) 2004-12-30 2006-07-06 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a growing animal
RU2403800C2 (ru) * 2004-12-30 2010-11-20 Хилл`С Пет Ньютришн, Инк. Композиция для кошачьего потребления
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
EP1896077B1 (en) * 2005-06-29 2012-08-15 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of inflammatory disease
ES2275435B1 (es) * 2005-11-18 2008-06-01 Farmaleis, S.L. "composicion farmaceutica que comprende escualeno y uso de la misma para la preparacion de un medicamento para el tratamiento del cancer.
JP5452501B2 (ja) * 2007-12-21 2014-03-26 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ペット用飼料組成物
AU2013200758B2 (en) * 2008-07-18 2014-06-12 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
NO341929B1 (no) * 2009-09-14 2018-02-19 Chemoforma Ltd Fôrsammensetning
CN103347403B (zh) 2011-02-02 2016-04-20 雀巢产品技术援助有限公司 高蛋白质营养组合物及其制备和应用方法
RU2631597C2 (ru) 2011-07-15 2017-09-25 Нусерт Сайенсиз, Инк. Композиции и способы модулирования метаболических путей
SG10201709195TA (en) 2012-11-13 2017-12-28 Nusirt Sciences Inc Compositions and methods for increasing energy metabolism
WO2014149280A1 (en) * 2013-03-15 2014-09-25 Nusirt Sciences, Inc. Treatment of pets with sirtuin activators
CN105228627B (zh) 2013-03-15 2018-07-13 纽斯尔特科学公司 亮氨酸和烟酸降低脂质水平
KR20160119863A (ko) 2014-02-27 2016-10-14 뉴서트 사이언시스, 인크. 간 지방증의 감소 또는 예방을 위한 조성물 및 방법
AU2019355862B2 (en) 2018-10-01 2021-04-22 Wintermute Biomedical, Inc. Therapeutic compositions
EP4017276A1 (en) 2019-12-19 2022-06-29 Hill's Pet Nutrition, Inc. Compositions comprising a particular ratio of insoluble to soluble fibre for use in the treatment of e.g. anxiety
AU2019478729B2 (en) * 2019-12-19 2024-08-29 Hill's Pet Nutrition, Inc. Reagents, kits and methods for assessing and reducing risk of developing canine hypothyroidism and other autoimmune conditions
EP4586824A1 (en) 2022-09-14 2025-07-23 Société des Produits Nestlé S.A. Compositions and methods utilizing southern ocean mackerel oil for providing health benefits in an animal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282254A (en) * 1979-10-04 1981-08-04 General Foods Corporation Dog food of improved acceptability
JP2723243B2 (ja) * 1988-02-25 1998-03-09 サントリー株式会社 高度不飽和脂肪酸添加動物飼料
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
JPH0638708A (ja) * 1992-05-15 1994-02-15 Earth Chem Corp Ltd ナトリウム吸収阻害剤、ナトリウム吸収阻害剤を含有する高血圧予防食品、及び高血圧治療剤
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses

Also Published As

Publication number Publication date
WO1997013415A1 (en) 1997-04-17
AU7254596A (en) 1997-04-30
NO981593D0 (no) 1998-04-07
CA2234249A1 (en) 1997-04-17
EP0854681B1 (en) 2001-12-19
EP0854681A1 (en) 1998-07-29
JP4216334B2 (ja) 2009-01-28
JPH11513561A (ja) 1999-11-24
BR9611044A (pt) 1999-12-28
NZ319911A (en) 1998-12-23
MXPA98002779A (es) 2003-08-08
AU707341B2 (en) 1999-07-08
ES2170269T3 (es) 2002-08-01
ATE210928T1 (de) 2002-01-15
DE69618218D1 (de) 2002-01-31
NO981593L (no) 1998-06-09
CA2234249C (en) 2002-03-26
TR199800744T2 (xx) 1998-08-21
US5776913A (en) 1998-07-07
NO325357B1 (no) 2008-04-07
DK0854681T3 (da) 2002-04-15
DE69618218T2 (de) 2002-08-22

Similar Documents

Publication Publication Date Title
ZA968482B (en) Therapeutic diet for metabolic abnormalities found in dogs with lymphoma.
Christie The effects of diet and other factors on the lipid composition of ruminant tissues and milk
AU2002303744B2 (en) A method of improving the flavor, tenderness and overall consumer acceptability of poultry meat
Mansbridge et al. Nutritional factors affecting the fatty acid composition of bovine milk
Ashes et al. Incorporation of n− 3 fatty acids of fish oil into tissue and serum lipids of ruminants
Hulan et al. Omega-3 fatty acid levels and general performance of commercial broilers fed practical levels of redfish meal
NZ510932A (en) Animal feed additive composition comprising at least two antimicrobial enzymes and one or more PUFAs for feeding to pigs, poultry, veal calves and fish
AU2002303744A1 (en) A method of improving the flavor, tenderness and overall consumer acceptability of poultry meat
Jenkins Feeding oleamide to lactating Jersey cows 1. Effects on lactation performance and milk fatty acid composition
Kennedy et al. Influence of dietary conjugated linoleic acid (CLA) on lipid and fatty acid composition in liver and flesh of Atlantic salmon (Salmo salar)
Annett et al. Effects of source and level of fish oil supplementation in late pregnancy on feed intake, colostrum production and lamb output of ewes
CA2524451A1 (en) Rumen bypass calcium salts of trans and polyunsaturated fatty acids
JPS5780377A (en) Ruminant animal feed improving additive
Witter et al. The influence of the amount and nature of dietary fat on milk fat composition in the sow
US4764532A (en) Treatment of horses
JPS61149054A (ja) キヤツトフ−ド組成物
Baustad Cottonseed meal in the feeding of growing pigs
KUROSHIMA et al. Nutritional quality of the wild zooplankton as a living feed for fish larvae
Szumacher-Strabel et al. Effect of protected fat on fatty acid composition and conjugated linoleic acid level in meat and milk of sheep
Gi et al. Effect of dietary Sargassum meal on growth and body composition of ayu (Plecoglossus altivelis) reared in seawater
Ames et al. Biochemical studies on vitamin AX A nutritional investigation of synthetic vitamin A in margarine
Sawosz et al. Influence of dietary lecithin and oils rich in n-3 polyunsaturated fatty acids (PUFA) on the fatty acid content of rat muscle and serum
Or-Rashid et al. Supplemental algal-meal alters the ruminal trans-18: 1 fatty acid and CLA 3 composition in cattle
Astrup et al. Feeding of various hydrogenated marine oil products to the dairy cow
Lewis et al. Biological Properties in Relation to Chick Growth of Acid Proteases from Aspergillus SP and Rhizopus SP